A multicentre randomised placebo-controlled double-blind study on adjuvant treatment of mediastinitis with immunoglobulins (Pentaglobin) after cardiac surgery (ATMI): outline and preliminary study protocol for discussion. The ATMI Study Group.
We present the second draft of a consensus-assisted protocol on the adjuvant treatment after cardiac surgery with immunoglobulins of mediastinitis. CLINICAL PHASE: Phase III. Placebo-controlled investigation of the clinical efficacy of Pentaglobin (Biotest, Germany) as an added treatment in patients with mediastinitis. Group A, active Pentaglobin; Group B, placebo: 5% glucose solution with 1% human albumin. 5 ml/kg body weight Pentaglobulin or placebo intravenously each day for 5 days. Prospective, placebo-controlled, double blind, randomised, multicentre. n = 100; 50 patients with Pentaglobin (active), 50 patients with placebo. Cumulative therapeutic intervention scoring system (TISS-28) during hospital stay.